David A. Karnofsky
David A. Karnofsky publishes mostly in Molecular Biology, Oncology and Public Health, Environmental and Occupational Health, on topics such as Acute Lymphoblastic Leukemia research, Cancer Treatment and Pharmacology and Cancer therapeutics and mechanisms.
- World rank
- #76,268 of 7,710,434 ranked researchers
- Rank in United States
- #29,435 of 1,627,098
- Works
- 146
- Citations
- 10k
- Citations per work
- 71.6
What does David A. Karnofsky research?
David A. Karnofsky's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else8457.8%
- Health Sciences4430.2%
- Medicine4430.2%
- Life Sciences1812.0%
- 1Molecular Biology12% of their works
- 2Oncology9% of their works
- 3Public Health, Environmental and Occupational Health8% of their works
- 4Pulmonary and Respiratory Medicine4% of their works
- 5Pediatrics, Perinatology and Child Health4% of their works
- 6Endocrinology, Diabetes and Metabolism4% of their works
Research topics
Which keywords describe David A. Karnofsky's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Acute Lymphoblastic Leukemia, Childhood Cancer, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, DNA and EGFR Mutations.
- Transgenic Animals
- Lymphoma
- Classification
- Pediatric Quality of Life Inventory
- Topoisomerases
- EGFR Mutations
- Taxanes
- Childhood Cancer
- Rituximab
- Prognostic Factors
- Acute Lymphoblastic Leukemia
- Chemotherapy-Induced Peripheral Neuropathy
- DNA
- Targeted Therapy
- Childhood Cancer Survivor Study
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Genetic Modification
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Prognostic Factors252 topics
- Rituximab182 topics
- Acute Lymphoblastic Leukemia161 topic
- Childhood Cancer161 topic
- Chemotherapy-Induced Peripheral Neuropathy141 topic
- Taxanes141 topic
- DNA111 topic
- EGFR Mutations111 topic
- Targeted Therapy111 topic
- Topoisomerases111 topic
- Childhood Cancer Survivor Study101 topic
- Pediatric Quality of Life Inventory101 topic
- Chronic Lymphocytic Leukemia91 topic
- Classification91 topic
- Genomic Aberrations91 topic
- Lymphoma91 topic
- Genetic Modification61 topic
- Transgenic Animals61 topic
Where does David A. Karnofsky work?
David A. Karnofsky's main affiliation in the publication record is Kettering University, United States.
How many publications and citations does David A. Karnofsky have?
OpenAlex counts 146 works and 10,453 citations for David A. Karnofsky, an h-index of 40, ranking #76,268 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David A. Karnofsky. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.